Stock Price Quote

BERYL DRUGS LTD.

NSE : NABSE : 524606ISIN CODE : INE415H01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE39.360.21 (+0.54 %)
PREV CLOSE ( ) 39.15
OPEN PRICE ( ) 39.93
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7902
TODAY'S LOW / HIGH ( )38.65 41.87
52 WK LOW / HIGH ( ) 11.6544.98
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 24-08 1993
Management Info
Sudhir Sethi - Chairman Sanjay Sethi - Managing Director
Registered Office

Address Ground Floor, 133,Kanchan Bagh,,
Indore,
Madhya Pradesh-452001

Phone 0731-2517677

Email beryldrugs25@yahoo.com

Website www.beryldrugs.com

Registrars Details
Adroit Corporate Services Pvt Ltd
19, Jaferbhoy Industrial Estate ,Makwana Road, Marol Naka,Andheri (E),Mumbai
Listing : BSE, Ahmedabad

NEWS

07Oct Beryl Drugs informs about compliance c
Beryl Drugs has informed that with reference to various conditions stipu..
15Mar Beryl Drugs informs about disclosure
Beryl Drugs has informed that the Exchange has received the disclosure u..
04Nov Beryl Drugs informs about board meeting
Beryl Drugs has informed that the 42nd meeting of the Board of the Direc..
22Oct Beryl Drugs informs about compliance c
With reference to various conditions stipulated under the SEBI (Listing..
05Sep Beryl Drugs informs about press release
Beryl Drugs has informed that it enclosed Newspaper Publication on sched..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit3.099999999999997.66000000000001
Gross Profit 3.74999999999999 9.84000000000001
Operating Profit 7.9599999999999922.14
Net Sales 76.6271.57

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4569.90 (4.30%)
M.Cap ( in Cr)20906.26
Neuland Laboratories (BSE)
peergroup  7102.20 (0.54%)
M.Cap ( in Cr)9112.04
Bajaj Healthcare (BSE)
peergroup  356.30 (11.20%)
M.Cap ( in Cr)983.33
Caplin Point Lab (BSE)
peergroup  1452.35 (1.89%)
M.Cap ( in Cr)11029.40
Jenburkt Pharma (BSE)
peergroup  787.20 (3.23%)
M.Cap ( in Cr)347.41

Shareholding Pattern

NON-INSTITUTION 73.62%
PROMOTERS 26.38%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Beryl Drugs Ltd.

Beryl Drugs Ltd. was incorporated in the year 1993. Its today's share price is 39.36. Its current market capitalisation stands at Rs 19.96 Cr. In the latest quarter, company has reported Gross Sales of Rs. 268.88 Cr and Total Income of Rs.271.66 Cr. The company's management includes Neha Sharma, Shreya Saraf, Abhinav Naik, Sudhir Sethi, Sanjay Sethi.

It is listed on the BSE with a BSE Code of 524606 , NSE with an NSE Symbol of and ISIN of INE415H01017. It's Registered office is at Ground Floor, 133,Kanchan Bagh,Indore-452001, Madhya Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Prateek Jain & Co, Subhash Chand Jain Anurag & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.